Overview

Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage (REDUCE)

Status:
Recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering blood pressure in brain hemorrhage survivors
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
American Heart Association
Treatments:
Spironolactone